UBC-based, independent, evidence-informed, practical #BetterPrescribing information for physicians, nurse practitioners, & pharmacists #MedEd #CME RT≠endorse
Vancouver, Canada
Joined August 2009
- Tweets8.3K
- Following3.6K
- Followers7K
- Likes7.3K
Therapeutics Initiative (TI) retweeted
🆕 #Cochrane Hypertension protocol 🆕
Blood pressure targets for hypertension in people with diabetes mellitus: doi.org/10.1002/14651858.CD0…
#hypertension #bloodpressure #diabetes
Therapeutics Initiative (TI) retweeted
A nice review of basic but essential pharmacokinetics forr #pharmacists
Simple clinical pharmacology can improve #prescribing
ICYMI: Our UBC TI Therapeutics Letter 142 explores simple pharmacokinetic principles that can assist clinicians to prescribe more efficiently + avoid common problems
👉🏽 ti.ubc.ca/letter142
#medsafety #MedEd #ptsafety
Therapeutics Initiative (TI) retweeted
Dr Juurlink est toujours très intéressant en conférence. Si vous voulez voir la pharmacothérapie de la douleur d’un autre œil, je vous conseille ce webinaire.
🆕 WEBINAR RECORDING 🆕
Dr. David Juurlink: Treating #pain is harder than it looks 🤕
✅ Why the goal of treating pain is not simply pain relief
✅ The many hidden harms of analgesics
✅ Myths about common analgesics
👉 ti.ubc.ca/2026/03/24/treatin…
#MedEd #opioids
Therapeutics Initiative (TI) retweeted
Examining HbA1c in Frail Older Adults: A Linked Data Cohort Study by @GidMK et al ti.ubc.ca/2026/04/22/examini… via @Drug_Evidence @lucypgeridoc
Therapeutics Initiative (TI) retweeted
HOW OFTEN... should A1c tests be used to monitor patients with #T2DM? 🤔
👉 UBC TI Letter + patient handout: ti.ubc.ca/letter161
"For patients with stable type 2 diabetes meeting glycemic goals, monitoring HbA1c every 6 months is as effective as every 3 months"
#MedEd
Therapeutics Initiative (TI) retweeted
Aumento en las dosis de inhibidores de la bomba de protones: ¿un truco de magia?
| Therapeutics letter
@Drug_Evidence
fundacionfemeba.org.ar/blog/…
Therapeutics Initiative (TI) retweeted
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/14651858.CD0…
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Therapeutics Initiative (TI) retweeted
🆕 UBC TI #Deprescribing series webinar 🆕
👉Watch the recording here:
ti.ubc.ca/deprescribing-webi…
Case: Deprescribing multiple psychotropic medications
Presenter: Cara Mills, Clinical Pharmacist
#MedEd #CME #antidepressants #mentalhealth
Therapeutics Initiative (TI) retweeted
🆕 More UBC TI Educational events are on the way!
SAVE THE DATES + watch our Events and Webinars page for more details: ti.ubc.ca/continuing-educati…
Registration is now open for our next #Deprescribing webinar:
ti.ubc.ca/deprescribing-webi…
#CME #MedEd #BetterPrescribing
Therapeutics Initiative (TI) retweeted
👧🏼 Dispensing challenges
Medications prescribed for children often require precise calculations based on age, size, and weight, increasing the risk of dosing errors.
Therapeutics Initiative (TI) retweeted
Children are more vulnerable to #MedicationErrors due to unclear dosing guidelines and a lack of child-specific medications.
Learn more about the factors impacting child patients in the thread below👇 and read our #DeepDive for more 👉 ow.ly/F4q150W5qYF
Therapeutics Initiative (TI) retweeted
If you are interested in improving safe care of people with moderate to severe #frailty, this one page guideline from the British Geriatrics Society is so useful. For medicines review to balance benefit and risk. #polypharmacy #deprescribing
bgs.org.uk/sites/default/fil…
Therapeutics Initiative (TI) retweeted
We are delighted to share that our feasibility study results are now published in Research in Social and Administrative Pharmacy! 🎉
📄 Read here: doi.org/10.1016/j.sapharm.20…
A huge thank you to everyone who contributed to this work!
#Research #Pharmacy #Deprescribing
Therapeutics Initiative (TI) retweeted
BC family #physicians - are you interested in reviewing + assessing your #prescribing practices? 👩🏽⚕️👨🏼⚕️💊
Sign up to receive your confidential, personalized prescribing portrait from our TI Prescribing Portraits program: ti.ubc.ca/portrait
#BetterPrescribing #BetterHealth
Therapeutics Initiative (TI) retweeted
📰Noticias CADIME.
El boletín Therapeutics Letter ha publicado un artículo sobre citalopram y escitalopram, en el trastorno depresivo mayor y los trastonos de ansiedad.
CC @EASPsalud
Vía @Drug_Evidence
▶️Más información: easp.ws/cadimenoticias472025
Therapeutics Initiative (TI) retweeted
🧵 TI Annual Course - REGISTER NOW!
ti.ubc.ca/annual-course-2025
1/ Featuring expert speakers including the TI's Dr. Jessica Otte
"Drugs and edema: A not so ‘swell’ effect"
#DrugEvidence25 #CME #MedEd #BetterPrescribing
Therapeutics Initiative (TI) retweeted
Escitalopram frente a citalopram: marketing, no evidencia.
Misma efectividad y seguridad, doble precio.
Citalopram de primera elección.
En tratamientos ya iniciados, considerar la posibilidad de cambiar las prescripciones de escitalopram por citalopram a dosis equipotente de 2:1.
🆕 UBC TI Therapeutics Letter 159 🆕
Escitalopram vs citalopram
ti.ubc.ca/letter159
✅ Citalopram best choice for most new prescriptions
✅ Citalopram costs less + works just as well
#BetterPrescribing #prescribing #MedEd #antidepressants
Therapeutics Initiative (TI) retweeted
🚨 TI ANNUAL COURSE - SPECIAL PROMOTION FOR STUDENTS! 🚨
Our annual course is now almost full. For a limited time we're offering a number of complimentary (FREE) registrations to medical, pharmacy & nurse practitioner students/residents in BC.
Details:
ti.ubc.ca/annual-course-2025
Therapeutics Initiative (TI) retweeted
TI #BestEvidence webinar recording!
youtu.be/vXhWbRXvGpM
Dr. Davie Wong: Antimicrobial durations in practice - a product of magical thinking in medicine
✅ How we choose #antibiotics duration
✅ Recognize limitations of how we select durations
✅ Determining optimal duration
Therapeutics Initiative (TI) retweeted
ICYMI: TI Therapeutics Letter 157: How to🛑antidepressants
👉ti.ubc.ca/letter157
🐌 Avoid abrupt discontinuation
🖥️ Monitor patients after dose reduction
👩🏽🏫 Patient education + shared decision-making to minimize harms, improve outcomes
#deprescribing #MedEd #antidepressants
